$BVS Financial Misrepresentation Case

On January 3, 2023, Enovix (ENVX) conducted a presentation to shareholders during which new CEO Thurman Rodgers disclosed issues with both production lines with one line “doing less than 10% of what it should be doing,” and that revenues investors had previously been told to expect in early 2024 were no longer possible due to buildout delays.

On this news, Enovix shares dropped 41%, damaging investors.

Earlier On November 1, 2022, Enovix released a Letter to Shareholders about the Q3 2022 report in which it disclosed the revenue of only $8k, despite prior promises of delivering commercial products on a meaningful scale. Additionally, the letter disclosed that Enovix is altering previously announced commercialization timelines.

Taking all representations and appeared facts into account, Investors have reasons to suspect that the Company, its Leaders, and its Advisers overstated Enovix’s ability to produce batteries at scale, touting the Company’s “meaningful progress” in scaling up its manufacturing facility, and it's being positioned to deliver batteries ahead of competitions, despite its continued manufacturing issues.